INB-500

N/A

Report date: 2025/06/11 10:34:56

Base Information

Drug NameINB-500
Drug Alias Nameinduced pluripotent stem cell (iPSC)-derived allogeneic gamma-delta T cell therapy (IN8bio)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Gamma delta T-cell therapy
Mechanisms of ActionT lymphocytes modulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIN8BIO Inc
China Registration ClassN/A

Develop Information

Active CompaniesIN8BIO Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A